This topic contains a solution. Click here to go to the answer

Author Question: When the newly admitted patient with chronic obstructive pulmonary disease informs the nurse that ... (Read 35 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
When the newly admitted patient with chronic obstructive pulmonary disease informs the nurse that she frequently awakens during the night, the nurse may notify the physician for which of the following interventions?
 
  A) A hypnotic medication
  B) A narcotic medication
  C) Low-flow oxygen
  D) Warm milk

Question 2

Which of the following activities would be appropriate to suggest to the patient who states that she has difficulty falling asleep every evening?
 
  A) Take a warm shower before bedtime
  B) Drink a glass of milk with a turkey sandwich
  C) Exercise vigorously for 30 minutes before sleep
  D) Clean the bedroom prior to falling asleep



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mfedorka

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

Ans: C

Answer to Question 2

Ans: B




sheilaspns

  • Member
  • Posts: 567
Reply 2 on: Jul 22, 2018
Wow, this really help


AngeliqueG

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library